Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-04-001639
Filing Date
2004-06-29
Accepted
2004-06-29 14:49:38
Documents
3
Group Members
ORBIMED ADVISORS LLCORBIMED CAPITAL LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G sc13ga_062904-atrix.txt SC 13G/A 7628
2 JOINT FILING AGREEMENT ex1-1_062904.txt EX-1.1 1774
3 STATEMENT OF CONTROL PERSON ex2-1_062904.txt EX-2.1 612
  Complete submission text file 0000947871-04-001639.txt   12425
Mailing Address 2579 MIDPOINT DR FORT COLLINS CO 80525
Business Address 2579 MIDPOINT DR FORT COLLINS CO 80525 3034825868
ATRIX LABORATORIES INC (Subject) CIK: 0000809875 (see all company filings)

EIN.: 841043826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-40981 | Film No.: 04888301
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 THIRD AVENUE NEW YORK NY 10017
Business Address 767 THIRD AVENUE NEW YORK NY 10017 2127396400
ORBIMED CAPITAL LLC (Filed by) CIK: 0001157524 (see all company filings)

EIN.: 134133323 | State of Incorp.: DE | Fiscal Year End: 1231